Replies to post #537 on Repros Therapeutics Inc (RPRX)

[ThomasS]

imo, no big moves before Androxal FDA meeting; or, before biopsy dataset.

I agree it is still way undervalued, however, based on data in hand. By Sept we will be seeing big moves.

[charmed1]

Guestimate....

I think this takes us into upper teens over the summer...
We should be able to hold that level since we are still
undervalued....

The next catalyst will be the qol decision...if no qol
required I think that takes us to 20 to 25.....then if
bids emerge maybe 30 plus on an androxal bid...

then nothing else till proellex into 08

if androxal needs to do the qol..i think we range trade
between 17-22 for a while

other thoughts?